1. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man;Ahr;Arzneimittelforschung,1997
2. Smoothing effect of a new alpha-glucosidase inhibitor BAY m 1099 on blood glucose profiles of sulfonylurea-treated type II diabetic patients;Arends;Horm. Metab. Res.,1986
3. The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes;Chiasson;Diabetes Care,2001
4. Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study;Drent;Diabetes Nutr. Metab.,2002
5. Effect of alpha-glucosidase inhibition on glucose profiles in insulin dependent diabetes;Hillman;Diabetes Res.,1989